Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : Janssen Pharmaceuticals, Inc

Femme et Homme Max 99 ans
Janssen Pharmaceuticals, Inc MAJ Il y a 4 ans

A study comparing the safety and effects of a new compound, ACI-35 with placebo in patients with mild to moderate Alzheimer's disease Background and study aims Alzheimer’s disease (AD) is the most common cause of dementia, creating problems with memory, thinking and behaviour (cognitive function). It is a growing problem worldwide, ...

Pays Aucun
Organes Aucun
Spécialités Aucune

Essai clos aux inclusions

Plus d'informations